CD4 ⍣ T lymphocytes usually recognize peptides of 12-16 amino acids in the context of HLA class II molecules. We have recently used synthetic peptide combinatorial libraries to dissect in detail antigen recognition by autoreactive CD4 ⍣ T cell clones (TCC). The results of these studies demonstrated that antigen recognition by T cells is highly degenerate and that many cross-reactive ligands can be defined, some of which much more potent than the selecting autoantigen. Based on these observations, we examined the response of a myelin basic protein-specific HLA class II-restricted CD4 ⍣ TCC to truncation variants of optimal ligands. Surprisingly, pentapeptides, tetrapeptides and even tripeptides derived from different segments of the optimal ligands were recognized by the TCC, and some were even more potent than the selecting autoantigen. In addition, these peptides enhanced the survival of the TCC at low concentration. The relevance of this finding was supported by the generation of pentapeptide-specific CD4 ⍣ TCC from peripheral blood lymphocytes. These observations not only change existing views on the length requirements for activation of CD4 ⍣ HLA class II-restricted T cells, but also extend our knowledge about the flexibility of TCR recognition and the potential for cross-reactivity in the immune system.
Introduction
T cell activation of CD8 ϩ and CD4 ϩ T cells results from the functional outcome of the T cell response (8,9). Our recent data argue that, while there is a hierarchy in terms of the recognition of antigenic peptides in the context of self MHC class I or class II molecules respectively. In recent years, the importance of individual amino acids contacting the TCR, none of them is strictly required (10). Similar to what has been interaction between the TCR and the MHC-peptide ligand has been functionally analyzed (1) , and their crystal structures demonstrated for the interaction of the peptide with the MHC molecule (6,11), each amino acid of the peptide contributes elucidated (2) (3) (4) . It is now firmly established that peptides are able to bind to a given MHC molecule provided that the largely independently to the overall affinity between the TCR and the MHC-peptide complex (10). Whether T cell activation peptide contains the allele-specific anchor motifs (5,6). On the T cell side, productive engagement of the TCR with the will occur depends on a number of factors: the affinity of the TCR for the MHC-peptide complex (12), the density of TCR MHC-peptide complex will result when critical amino acids are present in certain positions of the peptide (7). However, and MHC-peptide complexes, as well as the expression of co-receptors, adhesion molecules and co-stimulatory molecit was also demonstrated that residues that are not in TCR contact positions can influence recognition and modulate the ules on the interacting cells (13, 14) .
With respect to peptide length, it was assumed that class with MBP and characterized as described (30) . The TCC is restricted by DR2b (DRα ϩ DRB1*1501). The TCR usage for II-associated peptides fall into a certain range of lengths to fulfill the above requirements. This notion stems from the TCC is TCRBV6S2. TCC CSF-3 was established with a limiting dilution split-well technique with a lysate of Borrelia sequencing MHC class II-associated self-peptides, from systematic binding studies (15, 16) , and from the elucidation of burgdorferi from the cerebrospinal fluid of a patient with chronic Lyme disease. The TCC recognizes several the X-ray crystal structure of MHC-peptide complexes (17,18). While the peptide length for MHC-restricted T cell responses B. burgdorferi-derived as well as human peptides in the context of DR2b. The TCR usage is TCRBV14 (26) . is generally thought to be 8-9 amino acids (class I) and 12-15 amino acids (class II), it was shown that shorter T cell proliferation peptides may be sufficient in certain instances, although at much higher concentrations (19-22).
TCC were rested for 8-12 days, washed and resuspended at 1ϫ10 5 cells/ml in complete medium (CM ϭ IMDM conWe and others have recently utilized synthetic peptide combinatorial libraries in the positional scanning format taining 5% human serum, 1% penicillin/streptomycin and 0.2% gentamicin). Then 100 µl of this cell suspension was (PS-SCL) to systematically assess the stimulatory value of each of the 20 naturally occurring L-amino acids at each added to each well of 96-well U-bottom plates containing 5ϫ10 4 irradiated (3000 rad) PBMC and varying concentrations position of the peptide and to define the spectrum of agonist ligands for individual T cell clones (TCC) (23) (24) (25) (26) . This of peptides. Cells were cultured at 37°C for 72 h or as indicated. During the last 8 h of culture, 1 µCi [ 3 H]thymidine approach has allowed the identification of agonist ligands for myelin basic protein (MBP)-specific TCC that were several was added to each well. Cells were then harvested and incorporated radioactivity was measured by scintillation orders of magnitude more potent than the autoantigenic peptide used to select the clone (24) . Here, we employ such counting. optimal ligands (effective in the lower picomolar range) to TCR signaling determine the minimal peptide length for HLA class II-restricted CD4 ϩ TCC. We demonstrate that even tripeptides HLA-matched B cells (2ϫ10 6 ) were pulsed with MBP peptide (83-99), or short peptides FFK, VVI or NVVI for 2 h at 37°C. and tetrapeptides can stimulate a CD4 ϩ TCC, and that stimulatory pentapeptides and tetrapeptides may be derived Antigen-presenting cells (APC) were then washed 3 times with T cell medium to remove unbound peptide. T cells from different segments of the optimal agonist ligand. Interestingly, these short peptides enhance T cell survival at low (1ϫ10 6 ) were added to the B cells and, after centrifugation (10 s at 1000 r.p.m.), were incubated at 37°C for 5 min. antigen concentration. Pentapeptides derived from MBP and from influenza virus hemagglutinin can also be used to Samples were then washed once with PBS and placed in lysis buffer [1% NP-40, 10 mM Tris-HCl, pH 7.2, 140 mM generate de novo specific CD4 ϩ TCC from peripheral blood lymphocytes. These data extend previous views on the NaCl, 2 mM EDTA, 5 mM iodoacetamide, 1 mM Na 3 VO 4 and complete protease inhibitor cocktail (Boehringer, Mannheim, minimal requirements for stimulation of CD4 ϩ HLA class II-restricted T cells and add the dimension of peptide length
Germany)] for 25 min on ice. After removing nuclear debris, lysate supernatants were subjected to immunoprecipito TCR degeneracy in recognition of antigen (25, 27) .
tation by incubation with rabbit anti-ZAP-70 (provided by Dr L. Samelson, NCI) at 4°C for 12 h. Samples were analyzed Methods by SDS-PAGE and immunoblotting with 4G10, a mouse mAb to phosphotyrosine (Upstate Biotechnology, Lake Placid, NY).
Peptides
T cell survival assays Peptides were initially synthesized by pin/F-moc techniques (Chiron Mimotopes, Clayton, Australia). To ensure the purity T cell survival assays were performed as described (31) . of the peptides and to exclude contamination by longer Seven days after re-stimulation of the TCC TL5F6, cells were peptides, the same set of antigens including all peptides Ͻ6
washed and resuspended at 2ϫ10 5 cells/ml. Then 100 µl of amino acids were resynthesized by simultaneous multiple the suspension was added to a 96-well U-bottom plate peptide synthesis (SMPS) methodology and purified by HPLC containing 5ϫ10 4 irradiated (3000 rad) PBMC and various (28) . The peptides were characterized using HPLC and concentrations of peptides. After 6 days, T cells were rechalmass spectrometry. Peptides were dissolved in H 2 O, except lenged with irradiated PBMC and MBP (83-99). Cells were peptides VVIFFKNVVIK and VIIFFKNVVIK that required the cultured for another 72 h at 37°C. During the last 8 h of addition of 0.1% acetic acid.
culture, 1 µCi [ 3 H]thymidine was added to each well. Cells were then harvested and incorporated radioactivity was measSynthesis and analysis of soluble peptide combinatorial libured by scintillation counting. Control cultures were set up raries under the same conditions to measure primary proliferative The decapeptide PS-SCL as well as subsequent peptide responses and cytokine secretion on day 3, 4, 5 and 6 after mixtures and individual peptides were synthesized using initial stimulation by the short peptides. In a flow cytometry-SMPS methodology as described (28, 29) .
based survival assay, 1ϫ10 5 rested T cells (TCC TL5F6) and 1ϫ10 5 PBMC were seeded in triplicate wells of U-bottom 96-TCC TL5F6 and CSF-3 well plates in the presence or absence of the short peptides (VVI, FFL, LRE and KDS, 10 µg/ml). After 5 days, T cells TCC TL5F6 was established from peripheral blood mononuclear cells (PBMC) by a limiting dilution split-well technique were stained with CyChrome-conjugated anti-CD3 antibody T  P  87  88  89  90  91  92  93  94  95  96 Amino acids corresponding to the most active mixtures deduced from the response of TCC TL5F6 to a decapeptide PS-SCL are displayed in the upper part of the table. Amino acids in parentheses represent mixtures due to frameshift of the PS-SCL (24) . The corresponding MBP sequence is displayed at the bottom. MHC anchor positions in the MBP sequence are indicated by boxes.
(PharMingen, San Diego, CA). Peripheral blood lymphocytes obtained by leukapheresis and countercurrent centrifugal elutriation were separately stained with a mixture of FITCconjugated anti-CD3 and -CD19 antibodies (Exalpha, Boston, MA), and added to the T cells at 3ϫ10 5 /condition. The survival rates were calculated as the number of CD3-CyChromepositive cells divided by the number of CD3/CD19-FITCpositive cellsϫ100.
T cell cloning with pentapeptides
TCC were established as described (30) . PBMC (2ϫ10 5 ) from (derived from influenza hemagglutinin). After 7 days, 10 U/ml PS-SCL screening ( Table 1 ). Note that each modification of MBP (86-rIL-2 (NCI, NIH) was added. After another 8 days, the cultures 96) towards the optimal peptide VVHFFKNVVIK enhances the potency were split to determine wells that contained antigen-specific of the peptide (differences in the peptide sequences are underlined).
T cells by proliferation. Positive wells were re-stimulated with
The background was 320 c.p.m.; averages Ϯ SD of duplicates for each data point are displayed. One representative experiment out of PBMC, peptide and IL-2, and re-tested at least twice to three is shown. confirm specificity. In parallel to the third test, a FACS phenotype analysis for the expression of CD4 and CD8 was performed on a FACSCalibur (Becton Dickinson, Mountain View, CA) using mAb (both from Becton Dickinson) as described a few mixtures induced strong stimulation of the TCC, whereas (32) .
all other mixtures in those positions elicited no response. The amino acids corresponding to the most active mixtures were Database search F, Y and A in position 4, the positively charged amino acids Database searches of SWISS-PROT for peptide sequences K and R in position 5, N in position 6, K, V and T in position or peptide motifs were performed with ScanProsite (http:// 7, I and V in position 8, aliphatic amino acids and A in position www.expasy.ch/sprot/scnpsit2.html).
9, and K in position 10 (Table 1) . Based on these results, we synthesized a number of optimal 10 amino acid (as well as some 11 amino acid) peptides and tested them for their Results relative potency in proliferation assays. The results with one Determination of optimal peptide ligands for TCC TL5F6 of these, decapeptide LIMFKNVVIK, is shown in Fig. 1 . Similar to our previous data (24) , peptides based on the TCR motif In order to define the minimal length requirements for an antigenic peptide recognized by a class II-restricted MBPdeduced from the response to PS-SCL were several orders of magnitude more potent than the corresponding 11 amino specific CD4 ϩ TCC, we selected a human TCC that showed a strong response to a decapeptide PS-SCL, thus allowing acid MBP peptide VVHFFKNIVTP. If the first 3 amino acids LIM were replaced by the three corresponding amino acids determination of optimal ligands as previously described (24, 25) . A summary of the results is shown in Table 1 . While of MBP (87-96) and an additional V added at the N-terminus, resulting in peptide VVHFFKNVVIK, no significant change many amino acids were tolerated in positions 1-3, mainly uncharged amino acids were optimal in position 1, aliphatic was observed, corresponding to the small differences observed with the PS-SCL in positions 1-3. However, substituand aromatic amino acids in position 2, whereas F, M and Q were stimulatory in position 3. In contrast, the requirements tion of P for K in position 11 decreased the stimulatory potency of the peptide. The exchange of T for I in position 10 reduced in positions 4-10 were much more discriminatory in that only LIMFKNVVIK variant, we synthesized a new set of short peptides based on all three peptides. The removal of the Nterminal K from peptide KNVVI improved recognition by one order of magnitude (Fig. 2B) . The resulting peptide NVVI was slightly more potent than the 11 amino acid MBP peptide (86-96) (data not shown). The N-terminal tetrapeptide of KNVVI, KNVV, was about two orders of magnitude less potent than NVVI and truncation of the N-terminal N further reduced recognition. However, even the tripeptide VVI was still recognized to a low extent at the highest concentration. It is important to note that this sequence occurs twice, at the N-and C-terminal of the 11 amino acid superagonist peptide VVIFFKNVVIK. To validate the above observations with peptides from the N-terminus, we truncated off the C-terminal 6 amino acids KNVVIK from one of the optimal 11 amino acid peptides (Fig. 2C) . The N-terminal pentapeptide VIIFF the two larger fragments, FFK. This peptide was considerably more potent than the tetrapeptide VIIF (Fig. 2C) . The fact that these short stimulatory peptides are contiguous in the native sequence raises the possibility that they simultaneously bind the response slightly, whereas I for V in position 8 (note, I is present in the native sequence) decreased it by several DRB1*1501 in two non-overlapping registers. This would be consistent with the DRB1*1501 binding motif, in which an orders of magnitude (Fig. 1) .
aromatic residue is favored in relative position i ϩ 3, whereas Definition of the minimal peptide length requirements for aliphatic residues are found in relative positions i and i ϩ TCC TL5F6 6 (16,33). However, combinations of short peptides derived from the Next, we assessed how truncation analogues of an optimal ligand would be recognized by the TCC. The stepwise sequence VVIFFKNVVIK (e.g. VVI and FFK or VVI and NVVI) were tested and did not enhance proliferation of the TCC removal of single amino acids from the N-terminus of peptide LIMFKNVVIK resulted in a decline of the stimulatory potency (data not shown). The response of the TCC to the short peptides was strictly by one or more orders of magnitude at a time ( Fig. 2A) . However, the truncated pentapeptide KNVVI was~1 log more HLA-DR2b-dependent. No response to the short peptides designed for TCC TL5F6 was obtained from various TCC of potent than the hexapeptide KNVVIK, indicating that the removal of the terminal lysine in the short peptide enhances different specificity. To confirm the importance of this finding we tested the response of the TCC to a decapeptide derived recognition.
Based on the surprising result that a pentapeptide stimufrom myelin oligodendrocyte glycoprotein (MOG) that overlaps with the MBP peptide in 7 amino acids, matching only 4 lated the CD4 ϩ TCC, we tested further truncations on both sides. Since the 11 amino acid long peptides VVIFFKNVVIK amino acids in the sequence (Fig. 3) . The peptide was recognized by the TCC although its potency was lower. and VIIFFKNVVIK were equally well tolerated as the However, the result demonstrates that even truncated peptides matching only a few amino acids of the optimal TCR motif can be recognized. Furthermore, we extended our observation to a DR2b-restricted CD4 ϩ TCC that recognizes several peptides derived from B. burgdorferi (26) . A potent decapeptide agonist was synthesized based on the response to PS-SCL (data not shown) and tested for proliferation (Fig. 4) . High stimulation indices were observed at 1). In T cells exposed to APC in the absence of peptide (lane 2), a slight increase in low mol. wt TCR ζ chain phospho-isoform p32 is concentrations of the short peptides Ͼ1 µg/ml (Fig. 4) , 
Short antigenic peptides activate early TCR signaling events
Recently, correlations between the stimulatory capacity of a ligand and specific patterns of phosphorylation of components of the TCR signaling apparatus as seen by Western blot employed two different kinds of survival assays, described in detail in Methods. The first assay (31) uses the proliferative have been described. We investigated the capacity of short peptides to induce modifications of the pattern of phosphorylacapacity of surviving T cells after exposure to substimulatory concentrations of short peptides as a readout for cell number. tion of the TCR z chain. In order to guarantee that only peptides able to bind and remain bound to MHC would
The proliferative capacity and therefore the total number of surviving cells (Fig. 6A) was greater in cultures which had present to the TCC, the APC to be used were pulsed with MBP peptide (83-99), or short peptides FFK, VVI or NVVI and been treated with short peptides than those exposed to autologous MHC with or without control peptides [LRE and subsequently washed before incubation with the T cells. While T cells which received no stimulation showed no signal, KDS; Fig. 6A ; influenza hemagglutinin (306-318); data not shown]. incubation with unpulsed B cells showed an increase in p32. Stimulation with MBP (83-99) induced a full-agonist pattern,
This effect occurred at concentrations that did not result in proliferation of the TCC measured 3-6 days after stimulation with p38 Ͼ p32. Stimulation with short peptides (FFK, VVI and NVVI) induced an increase in p32 and appearance of a (Fig. 6B) . Moreover, the short peptides that supported T cell survival did not induce significant secretion of cytokines p38 band (Fig. 5) , compatible with a partial agonist signaling pattern.
(IL-4, IFN-γ and IL-2) compared to control cultures without peptides (data not shown).
Tetrapeptides support T cell survival
The flow cytometry-based assay allows calculation of the survival rate as the percentage of T cells with respect to a The above data document that short peptide sequences are stimulatory for CD4 ϩ MHC class II-restricted TCC. To address standard reference (see Methods). T cells cultured for 5 days in the presence of APC and the short peptides VVI and FFK, whether they can also support the survival of autoreactive TCC as reported previously for altered peptide ligands, we but not the control peptides LDS and KRE, showed an the latter]. Positive cultures, established by split-well cloning, were stained for surface marker expression. CD4 expression of two clones specific for KNVVI is shown in Fig. 7 . Furthermore, these T cell cultures specifically proliferated upon increased survival rate (Table 2 ). These data demonstrate that tripeptides and tetrapeptides can support the survival of stimulation with pentapeptides underscoring that CD4 ϩ MHC class II-restricted T cell cultures can be generated with CD4 ϩ class II-restricted TCC.
pentapeptides from bulk PBMC, although their long-term Generation of CD4 ϩ MHC class II-restricted TCC with pentapropagation is difficult due to a lower stimulatory capacity peptides from peripheral blood lymphocytes than longer peptides. Following the observation that a CD4 ϩ MHC class II-restricted
Determination of the frequency of peptide mimics TCC can be stimulated by short peptide fragments derived from an optimal ligand, we reasoned that one should also be To determine the importance of the finding that 3-4 amino acid long peptides are recognized by TCC TL5F6, we wanted able to select for TCC with receptors that can be activated by short peptides from the peripheral blood. We therefore to know how frequently short peptide mimics can be found among all naturally occurring proteins reported so far. A cultured PBMC in the presence of either peptide KNVVI (derived from the TCR motif of TCC TL5F6) or KYVKQ [derived SWISS-PROT database sequence search was performed using the search engine ScanProsite with a set of truncated from influenza hemagglutinin (306-318); data not shown for Database search for mimicry peptides recognized by TCC TL5F6 using either short peptides that were recognized by the TCC or corresponding parts of the TCR motif as defined by the PS-SCL approach (tolerated amino acids for each position are shown in brackets, corresponding amino acids are underlined). The number of matches and the number of proteins that contain matched sequences are displayed.
peptide ligands derived from an optimal ligand. In addition, may promote the generation and presentation of short antigenic peptides (39) . In the current study, we demonstrate we searched the SWISS-PROT database with truncations of the degenerate TCR recognition motif of TCC TL5F6 as that truncation variants down to 3 amino acids can induce proliferation of a CD4 ϩ class II-restricted TCC. The variants defined by the PS-SCL approach. The results demonstrate that both peptide length and flexibility of the peptide sequence were generated from optimal peptides, as determined for a particular TCR by the PS-SCL approach. These optimal strongly influence the number of matches. Increasing numbers of sequence matches were found both with decreasing length sequences did not precisely match the peptide used to select the TCC in vitro, but were several orders of magnitude more of the peptide and increasing number of tolerated amino acids in each position (Table 3 ). The search demonstrates potent than the autoantigen (24) . Different truncated, but nonoverlapping segments of the peptide stimulated the TCC. the high frequency of cross-reactive ligands when a CD4 ϩ TCC can recognize tripeptides or tetrapeptides.
These short peptides also promoted T cell survival in vitro at concentrations even lower than those required for proliferation.
To confirm that recognition of short peptides is not a unique Discussion feature of TCC TL5F6 examined in this report, we extended the observation to another CD4 ϩ TCC for which truncated In recent years, the understanding of how T cells recognize peptide antigens has advanced significantly. It is now widely peptides defined by the PS-SCL approach maintained agonist properties (Fig. 4) (26) . We also established TCC with slightly accepted that in some T cells recognition is highly flexible in that many peptide ligands may lead to productive TCR longer peptides (5 amino acids) derived from two different sources (MBP and influenza hemagglutinin) from the periengagement and functionally elicit a graded response ranging from full agonism to partial/weak agonism to TCR antagonism pheral blood. These results confirm that T cell recognition at least in some T cells is extremely flexible not only in terms of (1). Although extensive studies have been performed with individual substitution analogues, the question of length MHC-peptide structure but also with respect to peptide length. requirements for peptide recognition has received little attention (11, 19, 34, 35 ). This is not surprising, since studies involThese data raise questions about which mechanisms underlie the interaction between the TCR and its MHC-peptide ving elution and sequencing of peptides from MHC molecules (5,15,16), peptide binding measurements (33) , T cell cloning ligand that allow recognition of tri-and tetrapeptides. A possible answer comes from recently resolved crystal strucexperiments and, in particular, the resolution of structures of the MHC-peptide complexes (17,18,36,37) have all indicated tures of TCR-MHC-peptide complexes (3, 4, 40) , showing that a large part of the flat contact surface between TCR and that 8-9 amino acids are necessary for MHC class I recognition and 12-16 amino acids for class II recognition. Following MHC-peptide complex is formed by direct TCR-MHC rather than TCR-peptide interactions. This suggests that the contristudies on the degeneracy of TCR recognition of antigen (24, 25) , here we investigated whether length requirements bution of the peptide to overall affinity in productive TCR engagement by peptide-MHC complexes may vary considerfor CD4 ϩ T cell activation may be less strict than previously believed, thereby representing a possible mechanism by ably (4). In certain instances of allorecognition, no peptide contribution may be required (41). More commonly, antigenic which this surprising flexibility is achieved. This appeared reasonable since short peptide fragments are likely to be peptides may lead to productive TCR engagement by modulating the pre-existing affinity between TCR and MHC. In this widely available throughout the body, especially in inflammatory sites when proteases and peptidases are activated in local case, the presence of short peptides is necessary and sufficient to overcome the threshold of TCR activation leading environments (38) . In central nervous system inflammation, extracellular degradation of MBP by matrix metalloproteases to effective signaling as evident from the appearance of the in T cell receptor recognition of a self peptide-MHC antigen.
high molecular weight TCR ζ chain phosphoisoform (p38; 
